G1 Therapeutics, Inc. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- G1 Therapeutics, Inc. Amended and Restated Clawback Policy (Filed With SEC on February 28, 2024)
- First Amend (Filed With SEC on November 1, 2023)
- Senior Advisor Agreement between Registrant and Jennifer K. Moses dated February 28, 2023 (Filed With SEC on March 1, 2023)
- Description of Securities of the Registrant (Filed With SEC on February 23, 2022)
- Scientific, Clinical, and Regulatory Advisor Agreement by and between the Registrant and Seth A. Rudnick, MD, effective July 1, 2021 (Filed With SEC on August 4, 2021)
- Description of Securities of the Registrant (Filed With SEC on February 24, 2021)
- Senior Advisor Agreement between Registrant and Mark A. Velleca, M.D., Ph.D. dated September 29, 2020 (Filed With SEC on November 4, 2020)
- Senior Advisor Agreement between Registrant and John E. Bailey, Jr. dated September 29, 2020 (Filed With SEC on November 4, 2020)
- Co-Promotion Agreement by and between the Registrant and Boehringer Ingelheim Pharmaceuticals, Inc., dated June 29, 2020 (Filed With SEC on August 5, 2020)
- Scientific, Clinical, and Regulatory Advisor Agreement, by and between the Registrant and Seth A. Rudnick, M.D., effective July 1, 2020 (Filed With SEC on August 5, 2020)
- Inducement Grant Option Agreement by and between the Registrant and Soma Gupta dated March 31, 2020 (Filed With SEC on May 6, 2020)
- Description of Securities of the Registrant (Filed With SEC on February 26, 2020)
- Amended and Restated 2017 Employee, Director and Consultant Equity Plan (Filed With SEC on August 8, 2018)
- DIRECTOR AGREEMENT (Filed With SEC on April 13, 2017)
- THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on April 13, 2017)
